Australia: Release of GM Sugarcane for Herbicide Tolerance
News Nov 18, 2009
The Gene Technology Regulator has made a decision to issue a licence in respect of application DIR 096 from BSES Limited (BSES). The applicant has received approval for the limited and controlled release of up to 6,000 sugarcane lines genetically modified for herbicide tolerance. The release is expected to take place at six BSES stations in the Queensland shires of Moreton Bay, Bundaberg, Mackay, Burdekin and Cairns on a maximum total area of 26 ha between November 2009 and November 2015. None of the GM sugarcane plants will be permitted to be used as human food or animal feed.
The decision to issue the licence was made after extensive consultation on the Risk Assessment and Risk Management Plan (RARMP) with the public, State and Territory governments, Australian Government agencies, the Minister for the Environment, Heritage and the Arts and the Gene Technology Technical Advisory Committee and relevant local councils, as required by the Gene Technology Act 2000 and corresponding State and Territory laws.
Issues relating to the health and safety of people and the protection of the environment raised during the consultation process on this application were considered in finalising the RARMP and in making the decision to issue the licence.
The Executive Summary, Technical Summary and complete finalised RARMP, together with a set of Questions and Answers on this decision and a copy of the licence, can be obtained on-line from the Office of the Gene Technology Regulator’s website
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.
Ancient Syphilis Genomes Decoded for First TimeNews
Researchers recovered three genomes of the bacterium Treponema pallidum from skeletal remains from colonial-era Mexico, and were able to distinguish the subspecies that causes syphilis from the subspecies that causes yaws. It was not previously thought possible to recover DNA from this bacterium from ancient samples.